Walters Group insider trades
Open-market stock purchases and sales by Walters Group, 10% Owner at Zentalis Pharmaceuticals, Inc, from SEC Form 4 filings since Dec 31, 2025.
Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging +35%.
Companies traded
- ZNTL Zentalis Pharmaceuticals, Inc: 2 buys, last Aug 14, 2026